Prevalence of antibodies against hepatitis A virus (HAV) in a population of Mexican children
Ramirez Mayans, J.A.; Cervantes Bustamante, R.; Jiron Castro, R.; Oyervides Garcia, C.I.; Mata Rivera, N.; Navarrete Delgadillo Natividad, M.A.; Sosa Martinez, M.C.
Acta Gastroenterologica Latinoamericana 27(2): 99-102
1997
ISSN/ISBN: 0300-9033 PMID: 9412137 Document Number: 477288
We studied by ELISA test 450 healthy children looking for IgG and IgM antibodies against virus A hepatitis. 376/450 (86.3%) showed IgG antibodies. 50% of children under one year were positive. At 3 years of age 80% of children from this study were with antibodies IgG and 96% of children at 10 years of age were positive. Only 9 children showed antibodies IgM.
Document emailed within 1 workday
Related Documents
Iancu, L.S.; Macovei, O.; Tourle, C.; Beadsworth, A.; Duca, M. 1996: The prevalence of anti-hepatitis C virus antibodies in children from social assistance units in the county of Iaşi Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 100(3-4): 109-113Stark, K.; Meyer, C.G.; Tacke, M.; Schwarz, A.; Braun, C.; Huzly, D.; Engel, A.M.; May, J.; Bienzle, U. 1997: Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors Transplantation 64(4): 608-612
Richardet, J.P.; Lons, T.; Johanet, C.; Abourached, A.; Raffoux, C.; Grimbert, S.; Sibony, M.; André, C.; Trinchet, J.C.; Homberg, J.C. 1994: Prevalence and characteristics of anti-tissue antibodies in chronic hepatitis caused by hepatitis C virus Gastroenterologie Clinique et Biologique 18(10): 819-823
Joshi, S.Kumar.; Ghimire, G.R. 2003: Serological prevalence of antibodies to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) among healthy Nepalese males--a retrospective study Kathmandu University Medical Journal 1(4): 251-255
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Sierra Madero, J.G.; Ponce de León, S.; Ruiz Palacios, G.; Tinoco, J.C.; Calva, J.J.; Zamora, E.E. 1986: Prevalence of antibodies against the lymphadenopathy-associated virus/human T-cell lymphotropic virus type IIi (LAV/HTLV) in a population of homosexuals in Mexico Salud Publica de Mexico 28(2): 180-185
Molesini, M.; Cinquetti, M.; Dolci, L.; Barlocco, E.G.; Marchi, D.; Vinco, A.; Zoppi, G. 1996: Prevalence of HCV antibodies and vertical transmission of hepatitis C virus La Pediatria Medica e Chirurgica: Medical and Surgical Pediatrics 18(1): 43-45
Montes, H.; Berrueta, L.; Cova, J.; Salmen, S.; Arribas, C.; Donis, J.; Hernandez, M. 1995: Prevalence of antibodies against hepatitis C virus in multitransfused patients G.E.N 49(2): 132-139
Singh, S.P.; Panda, C.; Pati, B.; Mishra, B.; Ray, S. 2003: Prevalence of antibodies to hepatitis C virus in coastal Orissa Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 22(6): 237
Selgas, R.; Martinez-Zapico, R.; Bajo, M.A.; Romero, J.R.; Munoz, J.; Rinon, C.; Miranda, B.; Miguel, J.L. 1992: Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 12(1): 28-30
Wu, J.S.; Lu, C.F.; Liu, W.T.; Lin, S.Y. 1991: Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 24(1): 55-60
Motta, M.; Brischetto, R.; Rapisarda, F.; Corno, C.; Rapisarda, C.; Fatuzzo, P.; Messina, A.; Biondi, A.; Mezzasalma, E.; Calcara, G. 1991: The prevalence of serum anti-hepatitis C virus antibodies in hemodialyzed patients Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 6(4): 375-378
Lin, S.C.; Shih, S.C.; Kao, C.R.; Chou, S.Y. 1995: Prevalence of antibodies to hepatitis C virus in patients with nonalcoholic fatty liver Zhonghua Yi Xue Za Zhi 56(2): 80-85
Fujiyama, S.; Kawano, S.; Sato, S.; Tanaka, M.; Goto, M.; Taura, Y.; Sato, T.; Kawahara, T.; Mizuno, K. 1992: Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff Hepato-Gastroenterology 39(2): 161-165
Hewitt, J.; Harte, D.; Sutherland, M.; Croucher, D.; Fouche, L.; Flanagan, P.; Williamson, D. 2018: Prevalence of hepatitis e virus antibodies and infection in New Zealand blood donors New Zealand Medical Journal 131(1469): 38-43
Mao, B.; Patel, M.K.; Hennessey, K.; Duncan, R.J.W.; Wannemuehler, K.; Soeung, S.Chan. 2013: Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia Vaccine 31(40): 4459-4464
Gohar, S.A.; Khalil, R.Y.; Elaish, N.M.; Khedr, E.M.; Ahmed, M.S. 1995: Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients Journal of the Egyptian Public Health Association 70(5-6): 465-484
Gessoni, G.; Manoni, F. 1993: Prevalence of anti-hepatitis C virus antibodies among teenagers in the Venetian area: a seroepidemiological study European Journal of Medicine 2(2): 79-82
Othman, B.M.; Monem, F.S. 2002: Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria Saudi Medical Journal 23(4): 393-395
Masqué, J.; Cano, P.; Ripoll, J.; García, R.M. 1993: The prevalence of the serological markers of the hepatitis B virus in a nonhospital population Atencion Primaria 12(2): 119-120